[go: up one dir, main page]

DK0727994T3 - Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac - Google Patents

Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac

Info

Publication number
DK0727994T3
DK0727994T3 DK93907465T DK93907465T DK0727994T3 DK 0727994 T3 DK0727994 T3 DK 0727994T3 DK 93907465 T DK93907465 T DK 93907465T DK 93907465 T DK93907465 T DK 93907465T DK 0727994 T3 DK0727994 T3 DK 0727994T3
Authority
DK
Denmark
Prior art keywords
etodolac
pain
optically pure
antipyretic
preparations containing
Prior art date
Application number
DK93907465T
Other languages
Danish (da)
English (en)
Inventor
Nancy M Gray
William J Wechter
James W Young
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK0727994T3 publication Critical patent/DK0727994T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93907465T 1992-03-13 1993-03-12 Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac DK0727994T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85322292A 1992-03-13 1992-03-13
US2983493A 1993-03-11 1993-03-11
PCT/US1993/002282 WO1993017680A1 (fr) 1992-03-13 1993-03-12 Procedes et compositions antipyretiques et analgesiques contenant de l'acide etodolique r optiquement pur

Publications (1)

Publication Number Publication Date
DK0727994T3 true DK0727994T3 (da) 2000-08-07

Family

ID=26705391

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907465T DK0727994T3 (da) 1992-03-13 1993-03-12 Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac

Country Status (9)

Country Link
US (1) US5561151A (fr)
EP (1) EP0727994B1 (fr)
JP (1) JPH07506817A (fr)
AT (1) ATE193648T1 (fr)
AU (2) AU3806393A (fr)
CA (1) CA2131992A1 (fr)
DE (1) DE69328838T2 (fr)
DK (1) DK0727994T3 (fr)
WO (1) WO1993017680A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN182040B (fr) * 1995-06-13 1998-12-12 American Home Prod
JP4234907B2 (ja) * 1998-05-15 2009-03-04 わかもと製薬株式会社 抗炎症点眼剤
AU767586B2 (en) 1998-07-09 2003-11-20 Cephalon, Inc. Methods and compositions for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) * 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7361680B2 (en) * 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) * 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
US6534676B2 (en) * 2001-01-31 2003-03-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
US6596686B2 (en) 2001-03-12 2003-07-22 International Flavors & Fragrances Inc. Use of dihydropyrans as fragrance Material
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
US20030232794A1 (en) * 2001-06-26 2003-12-18 Cottam Howard B. Use of STAT-6 inhibitors as therapeutic agents
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
TW200400963A (en) * 2002-05-21 2004-01-16 Wyeth Corp R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
AU2003295336A1 (en) * 2002-09-19 2004-04-08 Dennis A. Carson Use of etodoclac to treat hyperplasia
WO2005033112A2 (fr) * 2003-10-02 2005-04-14 Cephalon, Inc. Derives d'indole substitues
ZA200701719B (en) 2004-08-19 2008-05-28 Igt Reno Nev Gaming system having multiple gaming machines which provide bonus awards

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
NL170852C (nl) * 1968-03-27 1983-01-03 Ciba Geigy Ag Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van anti-inflammatoir werkzaam p-isoindolinylfenylazijnzuur en van derivaten hiervan.
FR2068425B1 (fr) * 1969-11-12 1973-01-12 Roussel Uclaf
US3843681A (en) * 1971-06-01 1974-10-22 American Home Prod 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US4501899A (en) * 1983-08-16 1985-02-26 American Home Products Corporation Resolution of (+)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cholesteryl aniline
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4515961A (en) * 1983-08-16 1985-05-07 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4,-b] indole-1-acetic acid using enrichment crystallization
US4544757A (en) * 1984-02-16 1985-10-01 American Home Products Corporation Process for the resolution of pyrano[3,4-b]indole-1-acetic acids
US4962124A (en) * 1987-11-17 1990-10-09 Analgesic Associates Onset-hastened/enhanced antipyretic response
US4927854A (en) * 1987-12-24 1990-05-22 Analgesic Associates Sustained/enhanced analgesia
DE3824353A1 (de) * 1988-07-19 1990-01-25 Paz Arzneimittelentwicklung Verfahren zur trennung von gemischen enantiomerer arylpropionsaeuren

Also Published As

Publication number Publication date
EP0727994A4 (fr) 1997-01-15
EP0727994B1 (fr) 2000-06-07
DE69328838T2 (de) 2000-10-12
JPH07506817A (ja) 1995-07-27
EP0727994A1 (fr) 1996-08-28
AU3999297A (en) 1997-12-18
WO1993017680A1 (fr) 1993-09-16
US5561151A (en) 1996-10-01
DE69328838D1 (de) 2000-07-13
CA2131992A1 (fr) 1993-09-16
ATE193648T1 (de) 2000-06-15
AU707780B2 (en) 1999-07-22
AU3806393A (en) 1993-10-05

Similar Documents

Publication Publication Date Title
DK0674511T3 (da) Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac
DK0727994T3 (da) Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DK0806948T3 (da) Behandling af urininkontinens ved anvendelse af (S)-oxybutynin og (S)-desethyloxybutynin
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DK0814796T3 (da) Anvendelse af et R-NSAID i en protektiv sammensætning til behandling af kolorektal cancer
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
GEP20063720B (en) Triamide-Substituted Indoles, Benzofuranes and Benzothiophenes as Inhibitors of Microsomal Triglyceride Transfer Protein (MTP) and/or Apolipoprotein B (Apo B) Secretion
EP1022025A3 (fr) Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur R(+)
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
NO20041166L (no) Anvendelse av optisk rent (+) norcisaprid sammen med et annet terapeutisk middel for fremstilling av et medikament
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
ATE225177T1 (de) Verwendung von (+)mefloquine zur behandlung von malaria
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
DK1124556T3 (da) Anvendelse af optisk rent (R)-tofisopam til behandling og forebyggelse af angstsygdomme
DE60013811D1 (de) Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen
NO169229C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-(3-alkyl-5-tert.butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner
ATE145825T1 (de) Behandlung von erhöhtem blutdruck
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren